CardioGen-82 PET Scan: Drug Safety Communication – Increased Radiation Exposure
Audience: Nuclear Medicine, Radiology, Patients ISSUE: FDA notified the public and the medical imaging community about the potential for inadvertent, increased radiation exposure in patients who underwent or will be undergoing cardiac positron…
Related posts:
- Angiotensin Receptor Blockers (ARBs): Drug Safety Communication – Drug Safety Review Completed Audience: Cardiology, Oncology, Family Practice [UPDATED 06/02/2011] FDA’s meta-analysis of...




facebook
rss
twitter